Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders

Seminars in Nuclear Medicine

Volumn 34, Issue 4, 2004, Pages 313-329

  El Haddad, Ghassan ^a   Zhuang, Hongming ^a   Gupta, Naresh ^b   Alavi, Abass ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Academic Radiology   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHEROSCLEROSIS; BACKACHE; BLOOD CLOT; BRAIN FUNCTION; DIAGNOSTIC PROCEDURE; ENTERITIS; ENVIRONMENT; EVALUATION; HUMAN; IMAGING; INFLAMMATION; JOINT; LUNG DISEASE; MONITORING; ORGAN TRANSPLANTATION; OSTEOMYELITIS; PLEURA DISEASE; PLEURA EFFUSION; PNEUMOCONIOSIS; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS; PYREXIA IDIOPATHICA; REVIEW; SARCOIDOSIS; STAGING; THYMUS HYPERPLASIA; THYROID NODULE; THYROIDITIS; VASCULITIS;

EID: 5544258354     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2004.06.006     Document Type: Article

References (217)

1. O. Warburg The Metabolism of Tumors 1930 Arnold Constable London 75 327
2. N. Avril, M. Menzel, J. Dose Glucose metabolism of breast cancer assessed by F-18-FDG PET Histologic and immunohistochemical tissue analysis J Nucl Med 42 2001 9 16
3. I. Ak, M.P.M. Stokkel, E.K.J. Pauwels Positron emission tomography with 2-[F-18]fluoro-2-deoxy-D-glucose in oncology Part II The clinical value in detecting and staging primary tumours J Cancer Res Clin Oncol 126 2000 560 574
4. S.M. Bakheet, J. Powe Benign causes of 18-FDG uptake on whole body imaging Semin Nucl Med 28 1998 352 358
5. K. Lehmann, M. Behe, J. Meller F-18-FDG uptake in granulocytesBasis of F-18-FDG scintigraphy for imaging infection [abstract] Basis of F-18-FDG scintigraphy for imaging infection [abstract] J Nucl Med 42 2001 1384
6. R. Chakrabarti, C.Y. Jung, T.P. Lee Changes in glucose-transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin J Immunol 152 1994 2660 2668
7. R.L. Gamelli, H. Liu, L.K. He Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice J Leukoc Biol 59 1996 639 647
8. N. Ahmed, M. Kansara, M.V. Berridge Acute regulation of glucose transport in a monocyte-macrophage cell line Glut-3 affinity for glucose is enhanced during the respiratory burst Biochem J 327 1997 369 375
9. S. Osman, H.J. Danpure The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labeling human granulocytes for clinical studies by positron emission tomography Int J Radiat Appl Instr 19 1992 183 190
10. L.A. Forstrom, B.P. Mullan, J.C. Hung F-18-FDG labelling of human leukocytes Nucl Med Commun 21 2000 691 694
11. T. Ishimori, T. Saga, M. Mamede Increased F-18-FDG uptake in a model of inflammation Concanavalin A-mediated lymphocyte activation J Nucl Med 43 2002 658 663
12. B.T. Heelan, S. Osman, A. Blyth Use of 2-[F-18]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography Transplantation 66 1998 1101 1103
13. R. Kubota, S. Yamada, K. Kubota Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo--High accumulation in macrophages and granulation tissues studied by microautoradiograph J Nucl Med 33 1992 1972 1980
14. Y. Sugawara, T.D. Gutowski, S.J. Fisher Uptake of positron emission tomography tracers in experimental bacterial infections a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, Ga-67-citrate, and I-125-HSA Eur J Nucl Med 26 1999 333 341
15. L.H. Brudin, S.O. Valind, C.G. Rhodes Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography Eur J Nucl Med 21 1994 297 305
16. A. Guhlmann, D. Brecht-Krauss, G. Suger Chronic osteomyelitis Detection with FDG PET and correlation with histopathologic findings Radiology 206 1998 749 754
17. S.J. Skehan, R. Issenman, J. Mernagh F-18-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease Lancet 354 1999 836 837
18. K.D.M. Stumpe, H. Dazzi, A. Schaffner Infection imaging using whole-body FDG-PET Eur J Nucl Med 27 2000 822 832
19. T. Tahara, Y. Ichiya, Y. Kuwabara High [18]-fluorodeoxyglucose uptake in abdominal abscesses A PET study J Comput Assist Tomogr 5 1989 829 831
20. S. Okazumi, K. Enomoto, M. Ozaki [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET] Kaku Igaku Jpn J Nucl Med 26 1989 793 797
21. M. Sasaki, Y. Ichiya, Y. Kuwabara Ringlike uptake of FDG in brain abscess A PET study J Comp Assist Tomog 14 1990 486 487
22. N. Tsuyuguchi, I. Sunada, K. Ohata Evaluation of treatment effects in brain abscess with positron emission tomography Comparison of fluorine-18- fluorodeoxyglucose and carbon-11-methionine Ann Nucl Med 17 2003 47 51
23. R.F. Yen, M.L. Chen, F.Y. Liu False-positive 2-[F-18]-fluoro-2-deoxy-D- glucose positron emission tomography studies for evaluation of focal pulmonary abnormalities J Formos Med Assoc 97 1998 642 645
24. Z. Kaya, J. Kotzerke, F. Keller FDG PET diagnosis of septic kidney in a renal transplant patient Transpl Int 12 1999 156
25. C.P. Bleeker-Rovers, R.G.L. de Sevaux, H.W. van Hamersvelt Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease Am J Kidney Dis 41 2003 E22
26. M. Zimny, W. Schroder, S. Wolters 18F-fluorodeoxyglucose PET in ovarian carcinoma methodology and preliminary results Nuklearmedizin 36 1997 228 233
27. W. Schroder, M. Zimny, C. Rudlowski The role of F-18-fluoro-deoxyglucose positron emission tomography (F-18-FDG PET) in diagnosis of ovarian cancer Int J Gynecol Cancer 9 1999 117 122
28. L.O. Kapucu, C.C. Meltzer, D.W. Townsend Fluorine-18-fluorodeoxyglucose uptake in pneumonia J Nucl Med 39 1998 1267 1269
29. S.M. Bakheet, M. Saleem, J. Powe F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection Clin Nucl Med 25 2000 273 278
30. F. Tahon, Y. Berthezene, S. Hominal Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings Eur Radiol 12 2002 S171 S173
31. H.A. Jones, R.J. Clark, C.G. Rhodes Positron emission tomography of 18FDG uptake in localized pulmonary inflammation Acta Radiol Suppl 376 1991 148
32. H.A. Jones, S. Sriskandan, A.M. Peters Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis Eur Resp J 10 1997 795 803
33. H. Zhuang, P.S. Duarte, M. Pourdehand Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging Clin Nucl Med 25 2000 281 284
34. Y. Sugawara, D.K. Braun, P.V. Kison Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography Preliminary results Eur J Nucl Med 25 1998 1238 1243
35. T. Kalicke, A. Schmitz, J.H. Risse Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases results of histologically confirmed cases Eur J Nucl Med 27 2000 524 528
36. A. Guhlmann, D. Brecht-Krauss, G. Suger Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis J Nucl Med 39 1998 2145 2152
37. H. Zhuang, P.S. Duarte, M. Pourdehnad The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants J Nucl Med 42 2001 44 48
38. B. Vanquickenborne, A. Maes, J. Nuyts The value of (18)FDG-PET for the detection of infected hip prosthesis Eur J Nucl Med Mol Imaging 30 2003 705 715
39. U. Cremerius, T. Mumme, P. Reinartz Analysis of F-18-FDG uptake patterns in PET for diagnosis of septic and aseptic loosening after total hip arthroplasty Nuklearmedizin-Nucl Med 42 2003 234 239
40. S.M.B. Bakheet, J. Powe, A. Ezzat F-18-FDG uptake in tuberculosis Clin Nucl Med 23 1998 739
41. T. Hara, N. Kosaka, T. Suzuki Uptake rates of F-18-fluorodeoxyglucose and C-11-choline in lung cancer and pulmonary tuberculosis--A positron emission tomography study Chest 124 2003 893 901
42. S. Reuter, H. Schirrmeister, W. Kratzer Pericystic metabolic activity in alveolar echinococcosis Assessment and follow-up by positron emission tomography Clin Infect Dis 29 1999 1157 1163
43. H. Ozsahin, M. von Planta, I. Muller Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B Blood 92 1998 2719
44. C. Franzius, M. Biermann, G. Hulskamp Therapy monitoring in aspergillosis using F-18FDG positron emission tomography Clin Nucl Med 26 2001 232 233
45. H. Zhuang, M. Pourdehnad, A.J. Yamamoto Intense F-18 fluorodeoxyglucose uptake caused by Mycobacterium avium intracellulare infection Clin Nucl Med 26 2001 458
46. M.J. O'Doherty, S.F. Barrington, M. Campbell PET scanning and the human immunodeficiency virus-positive patient J Nucl Med 38 1997 1575 1583
47. S.M.B. Bakheet, J. Powe, A. Kandil F-18FDG uptake in breast infection and inflammation Clin Nucl Med 25 2000 100 103
48. E. Kresnik, P. Mikosch, H.J. Gallowitsch F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease Clin Nucl Med 26 2001 867
49. A. Hannah, A.M. Scott, T. Akhurst Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis J Nucl Med 37 1996 1683 1685
50. M.A. Meyer Diffusely increased colonic F-18 FDG uptake in acute enterocolitis Clin Nucl Med 20 1995 434 435
51. M.B. Tomas, G.G. Tronco, G. Karayalcin FDG uptake in infectious mononucleosis Clin Position Imaging 3 2000 176
52. S. Yasuda, A. Shohtsu, M. Ide Elevated F-18 FDG uptake in plasmacyte-rich chronic maxillary sinusitis Clin Nucl Med 23 1998 176 178
53. P.J. Lewis, A. Salama Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis J Nucl Med 35 1994 1647 1649
54. G.J. Cook, I. Fogelman, M.N. Maisey Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning Potential for error in interpretation Semin Nucl Med 26 1996 308 314
55. Y. Yamada, Y. Uchida, K. Tatsumi Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis J Nucl Med 39 1998 1160 1166
56. H. Yamagishi, N. Shirai, M. Takagi Identification of cardiac sarcoidosis with N-13-NH3/F-18-FDG PET J Nucl Med 44 2003 1030 1036
57. S. Yasuda, S. Raja, K.F. Hubner Application of whole-body positron emission tomography in the imaging of esophageal cancer report of a case Surg Today 25 1995 261 264
58. I.K. Taylor, A.A. Hill, M. Hayes Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography Lancet 347 1996 937 940
59. A. Alavi, N. Gupta, J.L. Alberini Positron emission tomography imaging in nonmalignant thoracic disorders Semin Nucl Med 32 2002 293 321
60. M. Gysen, S. Stroobants, L. Mortelmans Proliferative myositis A case of a pseudomalignant process Clin Nucl Med 23 1998 836 838
61. S. Yasuda, A. Shohtsu, M. Ide Diffuse F-18 FDG uptake in chronic thyroiditis Clin Nucl Med 22 1997 341
62. M.B. Imran, K. Kubota, S. Yoshioka Sclerosing mediastinitis Findings on fluorine-18 fluorodeoxyglucose positron emission tomography Clin Nucl Med 24 1999 305 308
63. R.F. Nunez, H.W. Yeung, H. Macapinlac Increased F-18 FDG uptake in the stomach Clin Nucl Med 24 1999 281 282
64. W. Becker, D.M. Goldenberg, F. Wolf The use of monoclonal-antibodies and antibody fragments in the imaging of infectious lesions Semin Nucl Med 24 1994 142 153
65. E.M. de Kleijn, W.J. Oyen, F.H. Corstens Utility of indium-111-labeled polyclonal immunoglobulin G scintigraphy in fever of unknown origin. The Netherlands FUO Imaging Group J Nucl Med 38 1997 484 489
66. A. Fischman, J. Babich, H. Strauss A ticket to ride Peptide radiopharmaceuticals J Nucl Med 4 1993 2253 2263
67. C.J. van der Laken, O.C. Boerman, W.J. Oyen Scintigraphic detection of infection and inflammation New developments with special emphasis on receptor interaction Eur J Nucl Med 25 1998 535 546
68. O.C. Boerman, H. Rennen, W.J.G. Oyen Radiopharmaceuticals to image infection and inflammation Semin Nucl Med 31 2001 286 295
69. P. Laverman, W.J.G. Oyen, G. Storm Improved imaging of infection by avidin induced clearance of Tc-99m-biotin-PEG-liposomes J Nucl Med 39 1998 267P
70. F. De Winter, F. Gemmel, C. Van de Wiele Prospective comparison of Tc-99m ciprofloxacin (infection) SPECT and F-18 FDG PET for the diagnosis of chronic orthopaedic infections in the central skeleton (COICS) J Nucl Med 43 2002 477 [abstr]
71. F. De Winter, D. Vogelaers, F. Gemmel Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases Eur J Clin Microbiol Infect Dis 21 2002 247 257
72. H. Zhuang, M. Pourdehnad, E.S. Lambright Dual time point F-18-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 2001 1412 1417
73. A. Matthies, M. Hickeson, A. Cuchiara Dual time point F-18-FDG PET for the evaluation of pulmonary nodules J Nucl Med 43 2002 871 875
74. G.R. Conrad, P. Sinha Narrow time-window dual-point F-18-FDG PET for the diagnosis of thoracic malignancy Nucl Med Commun 24 2003 1129 1137
75. C.J. Palestro, M.A. Torres Radionuclide imaging in orthopedic infections Semin Nucl Med 27 1997 334 345
76. M. Perry Erythrocyte sedimentation rate and C reactive protein in the assessment of suspected bone infection--Are they reliable indices? J R Coll Surg Edinb 41 1996 116 118
77. L. Sanzen, M. Sundberg Periprosthetic low-grade hip infections-- Erythrocyte sedimentation rate and C-reactive protein in 23 cases Acta Orthop Scand 68 1997 461 465
78. U. Fluckiger, W. Zimmerli Diagnosis and follow-up management of postoperative bacterial osteomyelitis Orthopade 33 2004 416 423
79. W.A. Erdman, F. Tamburro, H.T. Jayson Osteomyelitis--Characteristics and pitfalls of diagnosis with MR imaging Radiology 180 1991 533 539
80. J.R. Crim, L.L. Seeger Imaging evaluation of osteomyelitis Crit Rev Diagn Imaging 35 1994 201 256
81. H.P. Ledermann, A. Kaim, G. Bongartz Pitfalls and limitations of magnetic resonance imaging in chronic posttraumatic osteomyelitis Eur Radiol 10 2000 1815 1823
82. F.L. Datz Indium-111 labeled leukocytes for the detection of infection Current status Semin Nucl Med 24 1994 92 109
83. J.E. Seabold, J.V. Nepola Imaging techniques for evaluation of postoperative orthopedic infections Qtr J Nucl Med 43 1999 21 28
84. A. Kaim, T. Maurer, P. Ochsner Chronic complicated osteomyelitis of the appendicular skeleton diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy Eur J Nucl Med 24 1997 732 738
85. A. Kaim, H.P. Ledermann, G. Bongartz Chronic post-traumatic osteomyelitis of the lower extremity comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies Skeletal Radiol 29 2000 378 386
86. A.F. Jacobson, C.P. Gilles, M.D. Cerqueira Photopenic defects in marrow-containing skeleton on in-111 leukocyte scintigraphy--Prevalence at sites suspected of osteomyelitis and as an incidental finding Eur J Nucl Med 19 1992 858 864
87. F. De Winter, C. Van de Wiele, D. Vogelaers Fluorine-18 fluorodeoxyglucose-positron emission tomography A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections J Bone Joint Surg Am 83A 2001 651 660
88. J. Meller, G. Koster, T. Liersch Chronic bacterial osteomyelitis prospective comparison of F- 18-FDG imaging with a dual-head coincidence camera and In-111-labelled autologous leucocyte scintigraphy Eur J Nucl Med 29 2002 53 60
89. F.C. Robiller, K.D.M. Stumpe, T. Kossmann Chronic osteomyelitis of the femur Value of PET imaging Eur Radiol 10 2000 855 858
90. A. Schmitz, J.H. Risse, J. Textor FDG-PET findings of vertebral compression fractures in osteoporosis Preliminary results Osteoporosis Int 13 2002 755 761
91. H. Zhuang, J.W. Sam, T.K. Chacko Rapid normalization of osseous FDG uptake following traumatic or surgical fractures Eur J Nucl Med Mol Imaging 30 2003 1096 1103
92. T.K. Chacho, H. Zhuang, K.Z. Nakhoda Application of fluorodeoxyglucose positron emission tomography in the diagnosis of infection Nucl Med Commun 24 2003 615 624
93. C.J. Palestro, C.K. Kim, A.J. Swyer Total-hip arthroplasty periprosthetic indium-111 labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection J Nucl Med 31 1990 1950 1954
94. D.M. Scher, K. Pak, J.H. Lonner The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties J Arthroplast 15 2000 295 300
95. A. Schmitz, H.J. Risse, T. Kalicke FDG-PET for diagnosis and follow-up of inflammatory processes First results from an orthopedic view Z Orthop Grenzg 138 2000 407 412
96. C. Love, P.V. Pugliese, M.O. Afriyie Utility of F18 FDG imaging for diagnosing the infected joint replacement Clin Postron Imaging 3 2000 159
97. H. Zhuang, T.K. Chacko, M. Hickeson Persistent non-specific FDG uptake on PET imaging following hip arthroplasty Eur J Nucl Med Mol Imaging 29 2002 1328 1333
98. T.K. Chacko, H. Zhuang, K. Stevenson The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses Nucl Med Commun 23 2002 851 855
99. N. Manthey, P. Reinhard, F. Moog The use of F-18 fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses Nucl Med Commun 23 2002 645 653
100. F. De Winter, C. Van de Wiele, D. De Clercq Aseptic loosening of a knee prosthesis as imaged on FDG positron emission tomography Clin Nucl Med 25 2000 923
101. K. Stumpe, H. Nötzli, M. Zanetti FDG PET for Differentiation of infection and aseptic loosening in total hip replacements Comparison with conventional radiography and three-phase bone scintigraphy Radiology 231 2004 333 341
102. D.C. Knockaert, L.A. Mortelmans, M.C. Deroo Clinical-value of Ga-67 scintigraphy in Evaluation of Fever of Unknown Origin Clin Infect Dis 18 1994 601 605
103. M.T. Syrjala, V. Valtonen, K. Liewendahl Diagnostic-significance of in-111 granulocyte scintigraphy in febrile patients J Nucl Med 28 1987 155 160
104. A.M. Peters Nuclear medicine imaging in fever of unknown origin Qtr J Nucl Med 43 1999 61
105. D. Blockmans, D. Knockaert, A. Maes Clinical value of [F-18]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin Clin Infect Dis 32 2001 191 196
106. J. Meller, G. Altenvoerde, U. Munzel Fever of unknown origin Prospective comparison of [F-18]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET Eur J Nucl Med 27 2000 1617 1625
107. J. Meller, C.O. Sahlmann, K. Lehmann F-18-FDG-hybrid-camera-PET in patients with postoperative fever Nuklearmedizin-Nucl Med 41 2002 22 29
108. C.P. Bleeker-Rovers, E. de Kleijn, F.H.M. Corstens Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation Eur J Nucl Med Mol Imaging 31 2004 29 37
109. I. Derdelinckx, A. Maes, J. Bogaert Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta Acta Cardiol 55 2000 193 195
110. A.M. Scharko, S.B. Perlman, P.W. Hinds Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques Proc Natl Acad Sci USA 93 1996 6425 6430
111. A.M. Scharko, S.B. Perlman, R.W. Pyzalski Whole-body positron emission tomography in patients with HIV-1 infection Lancet 362 2003 959 961
112. R. Levy, C. Mills, J. Posin The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients A prospective CT/MRI study J Acquir Immune Defic Syndr 3 1990 461 471
113. S. Porter, M. Sande Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome N Engl J Med 327 1992 1643 1648
114. R. Biggar, C. Rabkin The epidemiology of AIDS-related neoplasms Hematol Oncol Clin North Am 10 1996 997 1010
115. S.Y. Naddaf, M.F. Akisik, M. Aziz Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients Nucl Med Commun 19 1998 47 53
116. A. Antinori, A. Ammassari, R. Luzzati Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori Neurology 54 2000 993 997
117. J.M. Hoffman, A. WH, T. Schifter FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS J Nucl Med 34 1993 567 575
118. A.E. Heald, J.M. Hoffman, J.A. Bartlett Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET) Int J STD AIDS 7 1996 337
119. S. Yasuda, A. Shohtsu, M. Ide High fluorine-18 labeled deoxyglucose uptake in sarcoidosis Clin Nucl Med 21 1996 983 984
120. A. Alavi, C.A. Buchpiguel, A. Loessner Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med 35 1994 1650 1652 [editorial; comment]
121. R. Ross The pathogenesis of atherosclerosis A perspective for the 1990s Nature 362 1990 801 809
122. J. Strong, G. Malcom, C. McMahan Prevalence and extent of atherosclerosis in adolescents and young adults Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study JAMA 281 1999 727 735
123. H. Stary, A. Chandler, R. Dinsmore A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 92 1995 1355 1374
124. P. Libby, P. Ridker, A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
125. A. van der Wal, A. Becker, C. van der Loos Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
126. R. Ross Atherosclerosis--an inflammatory disease N Engl J Med 340 1999 115 126
127. L. Capron Chlamydia in coronary plaques--hidden culprit or harmless hobo? Nat Med 2 1996 856 857
128. J. Muhlestein, E. Hammond, J. Carlquist Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease J Am Coll Cardiol 27 1996 1555 1561
129. J. Muhlestein, J. Anderson, E. Hammond Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model Circulation 97 1998 633 636
130. A. Blum, M. Giladi, M. Weinberg High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis Am J Cardiol 81 1998 866 868
131. P. Sorlie, F. Nieto, E. Adam A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease The atherosclerosis risk in communities (ARIC) study Arch Intern Med 160 2000 2027 2032
132. M. Mayr, S. Kiechl, M. Mendall Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains Prospective results from the Bruneck study Stroke 34 2003 610 615
133. S. Vallabhajosula, J. Machac, K.K. Knesaurek Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG) (abstr) J Nucl Med 37 1996 144
134. M.J. Yun, S. Jang, A. Cucchiara F-18 FDG uptake in the large arteries A correlation study with the atherogenic risk factors Semin Nucl Med 32 2002 70 76
135. R.J. Lederman, R.R. Raylman, S.J. Fisher Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) Nucl Med Commun 22 2001 747 753
136. M. Tatsumi, C. Cohade, Y. Nakamoto Fluorodeoxyglucose uptake in the aortic wall at PET/CT Possible finding for active atherosclerosis Radiology 229 2003 831 837
137. G. Hunder, W. Arend, D. Bloch The American College of Rheumatology 1990 criteria for the classification of vasculitis Introduction. Arthritis Rheum 33 1990 1065 1067
138. J. Theron, J.L. Tyler Takayasus-arteritis of the aortic-arch - Endovascular treatment and correlation with positron emission tomography Am J Neuroradiol 8 1987 621 626
139. D. Blockmans, A. Maes, S. Stroobants New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography Rheumatology 38 1999 444 447
140. M. Hara, P.C. Goodman, R.A. Leder FDG-PET finding in early-phase Takayasu arteritis J Comput Assist Tomogr 23 1999 16 18
141. J. Meller, E. Grabbe, W. Becker Value of F-18FDG hybrid camera PET and MRI in early takayasu aortitis Eur Radiol 13 2003 400 405
142. J. Meller, F. Strutz, J. Siefker Early diagnosis and follow-up of aortitis with F-18 FDG PET and MRI Eur J Nucl Med Mol Imaging 30 2003 730 736
143. M. Webb, A. Chambers, A. Al-Nahhas The role of F-18-FDG PET in characterising disease activity in Takayasu arteritis Eur J Nucl Med Mol Imaging 31 2004 627 634
144. K. Balan, D. Voutnis, A. Groves Discordant uptake of F-18FDG and In-111WBC in systemic vasculitis Clin Nucl Med 28 2003 485 486
145. M. Brodmann, R.W. Lipp, A. Passath The role of 2-F-18-fluoro-2-deoxy-D- glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries Rheumatology 43 2004 241 242
146. R. Bar-Shalom, A.Y. Valdivia, M.D. Blaufox PET imaging in oncology Semin Nucl Med 30 2000 150 185
147. G. Moloney, I. Walker Talking about transplants social representations and the dialectical, dilemmatic nature of organ donation and transplantation Br J Soc Psychol 41 2002 299 320
148. S. Yasuda, M. Kubota, T. Tajima A small breast cancer detected by PET Jpn J Clin Oncol 29 1999 387
149. S.J. Hoff, J.R. Stewart, W.H. Frist Noninvasive detection of heart-transplant rejection with positron emission scintigraphy Ann Thorac Surg 53 1992 572 577
150. E. Rechavia, R. deSilva, S.S. Kushwaha Enhanced myocardial F-18-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography J Am Coll Cardiol 30 1997 533 538
151. H. Jones, T. Donovan, M. Goddard Use of 18FDG-PET to discriminate between infection and rejection in lung transplant recipients Transplantation 77 2004 1462 1464
152. E.M. Marom, H.P. McAdams, K.J. Butnor Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients J Thorac Imaging 19 2004 74 78
153. G.T. Smith, T.S. Wilson, K. Hunter Assessment of skeletal-muscle viability By PET J Nucl Med 36 1995 1408 1414
154. R.M. Aigner, G. Schultes, G. Wolf F-18-FDG PET Early postoperative period of oro-maxillo-facial flaps Nuklearmedizin-Nucl Med 42 2003 210 214
155. L. Kostakoglu, J. Wong, S. Barrington Speech-related visualization of laryngeal muscles with fluorine-18-FDG J Nucl Med 37 1996 1771 1773
156. T.F. Hany, E. Gharehpapagh, E.M. Kamel Brown adipose tissue a factor to consider in symmetrical tracer uptake in the neck and upper chest region Eur J Nucl Med Mol Imaging 29 2002 1393 1398
157. H.W.D. Yeung, R.K. Grewal, M. Gonen Patterns of F-18-FDG uptake in adipose tissue and muscle A potential source of false-positives for PET J Nucl Med 44 2003 1789 1796
158. S. Barrington, M. Maisey Skeletal muscle uptake of fluorine-18-FDG Effect of oral diazepam J Nucl Med 37 1996 1127 1129
159. M. Tashiro, T. Fujimoto, M. Itoh F-18-FDG PET imaging of muscle activity in runners J Nucl Med 40 1999 70 76
160. N. Oi, T. Iwaya, M. Itoh FDG-PET imaging of lower extremity muscular activity during level walking J Orthop Sci 8 2003 55 61
161. G. Pappas, E. Olcott, J. Drace Imaging of skeletal muscle function using (18)FDG PET Force production, activation, and metabolism J Appl Physiol 90 2001 329 337
162. G. Murrell, J. Walton Diagnosis of rotator cuff tears Lancet 357 2001 769 770
163. T. Shinozaki, K. Takagishi, A. Ichikawa Use of 2- F-18 -fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) imaging for the evaluation of muscle metabolic activity in ruptured rotator cuffs Identification of shoulder muscles by fusion imaging studies involving both FDG PET and magnetic resonance imaging J Shoulder Elbow Surg 12 2003 544 549
164. I. Bicik, P. Bauerfeind, T. Breitbach Inflammatory bowel disease activity measured by positron-emission tomography Lancet 350 1997 262
165. M.F. Neurath, M. Vehling, K. Schunk FDG-PET A novel non-invasive method to detect affected bowel segments in Crohn's disease? Gastroenterology 118 2000 1749
166. M.F. Neurath, D. Vehling, K. Schunk Noninvasive assessment of Crohn's disease activity A comparison of F-18-fluorodeoxlyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies Am J Gastroenterol 97 2002 1978 1985
167. P.D. Shreve, Y. Anzai, R.L. Wahl Pitfalls in oncologic diagnosis with FDG PET imaging physiologic and benign variants RadioGraphics 19 1999 61 77
168. F. Miraldi, H. Vesselle, P.F. Faulhaber Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer Clin Nucl Med 23 1998 3 7
169. B. Pio, F. Byrne, R. Aranda Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells Mol Imaging Biol 5 2003 271 277
170. G. Wagner Asbestosis and silicosis Lancet 349 1997 1311 1315
171. N. Lapp, V. Castranova How silicosis and coal workers' pneumoconiosis develop--a cellular assessment Occup Med 8 1993 35 56
172. P. Piguet, C. Vesin Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice Eur Respir J 7 1994 515 518
173. L.G. Strauss Fluorine-18 deoxyglucose and false-positive results A major problem in the diagnostics of oncological patients Eur J Nucl Med 23 1996 1409 1415
174. J. Konishi, K. Yamazaki, E. Tsukamoto Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer analysis of false-positive FDG-PET findings Respiration 70 2003 500 506
175. G.J.R. Cook, M.N. Maisey, I. Fogelman Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine Eur J Nucl Med 26 1999 1363 1378
176. W.E. Wallace, N.C. Gupta, A.F. Hubbs Cis-4- F-18 fluoro-L-proline PET imaging of pulmonary fibrosis in a rabbit model J Nucl Med 43 2002 413 420
177. H. Moskowitz, R. Platt, R. Schachar Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph Radiology 109 1973 33 35
178. F. Falaschi, L. Battolla, M. Mascalchi Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease AJR Am J Roentgenol 166 1996 963 968
179. C. Boutin, R. Loddenkemper, P. Astoul Diagnostic and therapeutic thoracoscopy Techniques and indications in pulmonary medicine Tuber Lung Dis 74 1993 225 239
180. C. Boutin, J. Viallat, P. Cargnino Thoracoscopy in malignant pleural effusions Am Rev Respir Dis 124 1981 588 592
181. F. Benard, D. Sterman, R. Smith Metabolic imaging of malignant mesothelioma with Fluorine-18-deoxyglucose positron emission tomography Chest 114 1998 713 722
182. H. Jadvar, A. Fischman Evaluation of rare tumors with [F-18]fluorodeoxyglucose positron emission tomography Clin Positron Imaging 2 1999 153 158
183. V.H. Gerbaudo, D.J. Sugarbaker, S. Britz-Cunningham Assessment of malignant pleural mesothelioma with F-18-FDG dual-head gamma-camera coincidence imaging Comparison with histopathology J Nucl Med 43 2002 1144 1149
184. S. Balogova, D. Grahek, K. Kerrou [18F]-FDG imaging in apparently isolated pleural lesions Rev Pneumol Clin 59 2003 275 288
185. D.B. Schneider, C. Clary-Macy, S. Challa Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma J Thorac Cardiovasc Surg 120 2000 128 133
186. J. Zubeldia, M. Abou-Zied, H. Nabi Evaluation of patients with known mesothelioma with 18F-fluorodeoxyglucose and PET. Comparison with computed tomography Clin Positron Imaging 3 2000 165
187. T.Z. Belhocine, F. Daenen, B. Duysinx Typical appearance of mesothelioma on an F-18FDG positron emission tomograph Clin Nucl Med 25 2000 636
188. F. Benard, D. Sterman, R. Smith Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography Chest 114 1998 713 722
189. F. Benard, A. Alavi, D. Sterman The prognostic value of FDG-PET imaging in malignant pleural mesothelioma J Nucl Med 39 1998 81P
190. T. Naruke, T. Goya, R. Tsuchiya Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
191. J.J. Erasmus, H.P. McAdams, S.E. Rossi FDG PET of pleural effusions in patients with non-small cell lung cancer Am J Roentgenol 175 2000 245 249
192. N.C. Gupta, J.S. Rogers, G.M. Graeber Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion Chest 122 2002 1918 1924
193. T. Bury, P. Paulus, A. Dowlati Evaluation of pleural diseases with FDG-PET imaging Preliminary report Thorax 52 1997 187 189
194. I. Buchmann, C. Guhlmann, K. Elsner [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes] Nuklearmedizin 38 1999 319 322
195. A. Carretta, C. Landoni, G. Melloni 18-FDG positron emission tomography in the evaluation of malignant pleural diseases--A pilot study Eur J Cardio-Thorac Surg 17 2000 377 382
196. P.M. Patel, H. Alibazoglu, A. Ali Normal thymic uptake of FDG on PET imaging Clin Nucl Med 21 1996 772 775
197. T. Nakahara, H. Fujii, M. Ide FDG uptake in the morphologically normal thymus Comparison of FDG positron emission tomography and CT Br J Radiol 74 2001 821 824
198. I. Brink, M. Reinhardt, S. Hoegerle Increased metabolic activity in the thymus gland studied with 18F-FDG PET Age dependency and frequency after chemotherapy J Nucl Med 42 2001 591 595
199. H. Alibazoglu, B. Alibazoglu, E.F. Hollinger Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose Clin Nucl Med 24 1999 597
200. F. Pagliai, L. Rigacci, V. Briganti PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma Leuk Lymphoma 44 2003 2015 2018
201. G. Hardy, S. Worrell, P. Hayes Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection HIV Med 5 2004 67 73
202. H. Uematsu, N. Sadato, T. Ohtsubo Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors J Nucl Med 39 1998 453 459
203. O. Drieskens, D. Blockmans, A. Van den Bruel Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis positron emission tomographic findings Clin Nucl Med 27 2002 413 415
204. D.T. Schmid, S. Kneifel, S.J. Stoeckli Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis Eur Radiol 13 2003 2119 2121
205. J. Santiago, S. Jana, H. El-Zeftawy Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease Clin Nucl Med 24 1999 714 715
206. M.S. Cohen, N. Arslan, F. Dehdashti Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography Surgery 130 2001 941 946
207. JT. Deichen, C. Schmidt, O. Prante Influence of TSH on uptake of F-18 fluorodeoxyglucose in human thyroid cells in vitro Eur J Nucl Med Mol Imaging 31 2004 507 512
208. F. Moog, R. Linke, N. Manthey Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma J Nucl Med 41 2000 1989 1995
209. T. Petrich, A.R. Borner, E. Weckesser Follow-up of thyroid cancer patients using rhTSH-- Preliminary results Nuklearmedizin-Nucl Med 40 2001 7 14
210. B.B. Chin, P. Patel, C. Cohade Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma J Clin Endocrinol Metab 89 2004 91 95
211. G.K. von Schulthess, N. Meier, K.D.M. Stumpe Joint accumulations of FDG in whole body PET scans Nuklearmedizin-Nucl Med 40 2001 193 197
212. W.E. Palmer, O.I. Schoenberg, A.J. Fischman FDG Metabolism in the wrist during treatment of inflammatory arthritis--Quantification with pet and correlation with clinical-response J Nucl Med 35 1994 35
213. A. Roivainen, R. Parkkola, T. Yli-Kerttula Use of positron emission tomography with methyl-C-11-choline and 2-F-18-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium Arthritis Rheum 48 2003 3077 3084
214. K.J. Chang, H. Zhuang, A. Alavi Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography Clin Nucl Med 25 2000 838 839
215. E.C. Lin, R.A. Quaife FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging Clin Nucl Med 26 2001 241 242
216. S. Raman, R. Nunez, C.O. Wong F-18FDG positron emission tomographic image of an aortic aneurysmal thrombus Clin Nucl Med 27 2002 213 214
217. P. Bhargava, R. Kumar, H. Zhuang Catheter-related focal FDG activity on whole body PET imaging Clin Nucl Med 29 2004 238 242